Live XELJANZ updates
Live XELJANZ news coverage of developments with the latest updates. Stay on top of latest XELJANZ news stories and find out what just happened, what is going on with XELJANZ. The latest real-time news updates and headlines on XELJANZ
Affordable Drugs Now Accessible for Multiple Cancer, Arthritis Types
11 Dec 2023 12:08 pm AEDT
XELJANZ PBS-Listed for pcJIA in Patients Aged 2 and Older
11 Dec 2023 5:06 am AEDT
April/May 2023 Safety Updates for TGA Products
05 Jun 2023 1:20 pm AEST
Janus Kinase Inhibitors: Important Safety Information
11 May 2023 12:22 pm AEST
Pfizer reports second-quarter 2022 results
28 Jul 2022 8:50 pm AEST
U.S. FDA Approves Pfizer's XELJANZ for Treatment of Active Ankylosing Spondylitis
15 Dec 2021 8:22 am AEDT
Pfizer reports third-quarter 2021 results
02 Nov 2021 9:58 pm AEDT
Pfizer reports second-quarter 2021 results
28 Jul 2021 8:54 pm AEST
Pfizer Provides Update on U.S. FDA Review of Abrocitinib and XELJANZ Filings
22 Jul 2021 7:14 am AEST
XELJANZ PBS-listed for patients with moderate-to-severe ulcerative colitis
05 Jul 2021 12:04 am AEST
Pfizer reports strong first-quarter 2021 results
04 May 2021 8:50 pm AEST
Pfizer reports fourth-quarter and full-year 2020 results and releases 5-YEAR pipeline metrics
02 Feb 2021 10:57 pm AEDT
Pfizer shares co-primary endpoint results
27 Jan 2021 10:56 pm AEDT
New rheumatoid arthritis treatment added to PBS
06 Oct 2015 4:08 pm AEDT